Listed companies such as Voltas, Blue Star, Amber, and Epack have submitted applications in this phase, with a proposed ...

While U.S. investors are benefiting from the crypto ETF surge, retail investors outside the U.S. face barriers in accessing ...

On Monday, Oppenheimer reiterated its Outperform rating and $42.00 price target for Pharvaris B.V. (NASDAQ: PHVS), a biopharmaceutical company. The reaffirmation follows a recent discussion with ...

DALLAS - Lantern Pharma Inc. (NASDAQ: LTRN) has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation ... companies investing heavily in R&D.

On Monday, Oppenheimer reiterated its Outperform rating and $42.00 price target for Pharvaris B.V. (NASDAQ: PHVS), a biopharmaceutical company. The reaffirmation follows a recent discussion with the ...

According to many mutual fund advisors, the large-cap category stands out as a potential performer during periods of market ...

Exchange-traded funds (ETFs) have revolutionized investing ... about 93% of the total market cap of all listed stocks in the U.S. equity market. The fund aims to closely track the index's return ...

Wales-based biotech company Antiverse has raised $4.6 million in seed funding. AI and biotech startups are continuing to ...

BOSTON - Elevation Oncology, Inc. (NASDAQ:ELEV) has received Fast Track designation from the U.S. Food and Drug ... Visit InvestingPro for an in-depth analysis and more expert tips to inform your ...

The company's regular quarterly payout of $0.15 per share plus February's special dividend of $0.18 per share puts it on track to dish out ... half the earnings of $1.93 per share that analysts ...

A specialist in macro investing, 93 East Capital fits the bill ... and provide monthly updates on our latest thinking on markets and the economy With a proven track record of delivering uncorrelated ...